nel to review the entire process of diagnosis, and the panel agreed the cause of th
上海千花坊e death needs to be determined by autopsy. The autopsy result is expected to be delivered within 45 to 60 working days.
Chinese vaccine against the Hepatitis E Virus (HEV) has entered clinical trial in the United Sta
tes after two US volunteers were vaccinated on May 1 (local time), according to Xiamen University.上海千花坊品茶微信
The trial will be carried out in three phases. The phase 1 clinical trial is schedule
d to enroll 25 US volunteers, and Phase 2 and 3 FDA-approved trials of the vaccine are expected to be done in a third country.
The vaccine, sold under the trade name Hecolin, was initially developed by a research team from Xiamen University in East China’s Fujian province and then transferred to and commercialized by the Xiamen Innovax Biotech Co., Ltd.上海千花坊
Hecolin has been used in China since 2012 for the prevention of hepatitis E.
上海千花坊品茶微信It has been approved by the US Food and Drug Administration (FDA) to enter a clinical trial in January.
It is the first time that FDA has given a green light to a Chinese vaccine to enter a clinical trial in the United States, accordin
g to Zhang Jun, deputy director of National Institute of Diagnostics and Vaccine Development in Infectious Diseases at Xiamen University.上海千花坊
According to Zhang, the trial was sponsored by the National Institutes of Health (NIH), the
primary agency of the US government responsible for biomedical and public health research.上海千花坊品茶微信
Hepatitis E is a liver disease caused by HEV, which is transmitted mainly through contaminated drinking water and
food. Large outbreaks of the disease have been reported in at least 30 countries in Africa, Asia and North America.